Fisher & Paykel Healthcare launches F&P my820 System for home-based respiratory humidification in the USA
Fisher & Paykel Healthcare Corporation Limited today announced the launch of the F&P my820 System into the United States.
The F&P my820 is the company’s latest respiratory humidifier for home mechanical ventilation. The F&P my820 System provides heated humidification during the delivery of invasive ventilation, noninvasive ventilation, and humidified high-flow therapies for adult and pediatric patients.
“The F&P my820 is the result of years of dedicated investment in new technologies that improve care and outcomes for patients in their homes,” said Andrew Somervell, Vice President – Products & Technology. “It provides peace of mind that adults and children can continue to receive high-quality care after they leave the hospital.”
Designed specifically to perform in home environments where temperatures can fluctuate, the F&P my820 System automatically adapts to environmental temperature changes using a built-in sensor. This sensor works to mitigate circuit condensate while also reducing device-wire clutter and providing patients with a simplified set-up process.
The F&P my820 System is currently available in Australasia, Europe, Canada and the United States, with more markets being added as regulatory clearances are received. DME customers in the United States can purchase the product starting 1 August 2024 by contacting their local Fisher & Paykel Healthcare sales representative. Product information can be found at fphcare.com.
The F&P my820 is the company’s latest respiratory humidifier for home mechanical ventilation. The F&P my820 System provides heated humidification during the delivery of invasive ventilation, noninvasive ventilation, and humidified high-flow therapies for adult and pediatric patients.
“The F&P my820 is the result of years of dedicated investment in new technologies that improve care and outcomes for patients in their homes,” said Andrew Somervell, Vice President – Products & Technology. “It provides peace of mind that adults and children can continue to receive high-quality care after they leave the hospital.”
Designed specifically to perform in home environments where temperatures can fluctuate, the F&P my820 System automatically adapts to environmental temperature changes using a built-in sensor. This sensor works to mitigate circuit condensate while also reducing device-wire clutter and providing patients with a simplified set-up process.
The F&P my820 System is currently available in Australasia, Europe, Canada and the United States, with more markets being added as regulatory clearances are received. DME customers in the United States can purchase the product starting 1 August 2024 by contacting their local Fisher & Paykel Healthcare sales representative. Product information can be found at fphcare.com.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Contacts:
|